These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32064279)

  • 1. Systemic atherosclerotic plaque vulnerability in patients with Coronary Artery Disease with a single Whole Body FDG PET-CT scan.
    Sánchez-Roa PM; Rees JI; Bartley L; Marshall C
    Asia Ocean J Nucl Med Biol; 2020; 8(1):18-26. PubMed ID: 32064279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study.
    Rudd JH; Myers KS; Bansilal S; Machac J; Woodward M; Fuster V; Farkouh ME; Fayad ZA
    Circ Cardiovasc Imaging; 2009 Mar; 2(2):107-15. PubMed ID: 19808576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of atherosclerotic inflammation and calcification in subjects with end stage renal disease (ESRD) on hemodialysis to normal controls utilizing
    Bural GG; Torigian DA; Sözmen M; Houseni M; Alavi A
    Hell J Nucl Med; 2018; 21(3):169-174. PubMed ID: 30411726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease.
    Rominger A; Saam T; Wolpers S; Cyran CC; Schmidt M; Foerster S; Nikolaou K; Reiser MF; Bartenstein P; Hacker M
    J Nucl Med; 2009 Oct; 50(10):1611-20. PubMed ID: 19759117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI.
    Fernández-Friera L; Fuster V; López-Melgar B; Oliva B; Sánchez-González J; Macías A; Pérez-Asenjo B; Zamudio D; Alonso-Farto JC; España S; Mendiguren J; Bueno H; García-Ruiz JM; Ibañez B; Fernández-Ortiz A; Sanz J
    J Am Coll Cardiol; 2019 Apr; 73(12):1371-1382. PubMed ID: 30922468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study.
    Duivenvoorden R; Mani V; Woodward M; Kallend D; Suchankova G; Fuster V; Rudd JHF; Tawakol A; Farkouh ME; Fayad ZA
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1087-1094. PubMed ID: 24135322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of atherosclerotic plaques on (18)F-FDG PET/MRI: comparison with a PET/CT hybrid system.
    Li X; Heber D; Rausch I; Beitzke D; Mayerhoefer ME; Rasul S; Kreissl M; Mitthauser M; Wadsak W; Hartenbach M; Haug A; Zhang X; Loewe C; Beyer T; Hacker M
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1503-12. PubMed ID: 26816195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of inflamed atherosclerotic lesions in vivo using PET-CT.
    Jezovnik MK; Zidar N; Lezaic L; Gersak B; Poredos P
    Inflammation; 2014 Apr; 37(2):426-34. PubMed ID: 24282108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [
    Ndlovu H; Lawal IO; Popoola GO; Brits B; Mokoala KMG; Maserumule LC; Hlongwa KN; Mahapane J; Davis C; Sathekge MM
    Ann Nucl Med; 2022 Jul; 36(7):684-692. PubMed ID: 35612698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between arterial FDG uptake and biomarkers in peripheral artery disease.
    Myers KS; Rudd JH; Hailman EP; Bolognese JA; Burke J; Pinto CA; Klimas M; Hargreaves R; Dansky HM; Fayad ZA
    JACC Cardiovasc Imaging; 2012 Jan; 5(1):38-45. PubMed ID: 22239891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thresholds for Arterial Wall Inflammation Quantified by
    van der Valk FM; Verweij SL; Zwinderman KA; Strang AC; Kaiser Y; Marquering HA; Nederveen AJ; Stroes ES; Verberne HJ; Rudd JH
    JACC Cardiovasc Imaging; 2016 Oct; 9(10):1198-1207. PubMed ID: 27639759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT.
    Ben-Haim S; Kupzov E; Tamir A; Israel O
    J Nucl Med; 2004 Nov; 45(11):1816-21. PubMed ID: 15534049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of age and cardiovascular risk factors on (18)F-FDG PET/CT quantification of atherosclerosis in the aorta and peripheral arteries.
    Pasha AK; Moghbel M; Saboury B; Gharavi MH; Blomberg BA; Torigian DA; Kwee TC; Basu S; Mohler Iii ER; Alavi A
    Hell J Nucl Med; 2015; 18(1):5-10. PubMed ID: 25679072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events, Evaluation of Colchicine Effectiveness (CADENCE): protocol for a randomised, double-blind, placebo-controlled trial.
    Boczar KE; Shin S; deKemp RA; Dowlatshahi D; Tavoosi A; Wiefels C; Liu P; Lochnan H; MacPherson PA; Chong AY; Torres C; Leung E; Tawakol A; Ahmadi A; Garrard L; Lefebvre C; Kelly C; MacPhee P; Tilokee E; Raggi P; Wells GA; Beanlands R
    BMJ Open; 2023 Nov; 13(11):e074463. PubMed ID: 37949621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-axial field-of-view PET/CT for the assessment of inflammation in calcified coronary artery plaques with [
    Mingels C; Sari H; Gözlügöl N; Bregenzer C; Knappe L; Krieger K; Afshar-Oromieh A; Pyka T; Nardo L; Gräni C; Alberts I; Rominger A; Caobelli F
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):422-433. PubMed ID: 37740742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
    Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
    J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carotid plaque inflammation assessed with (18)F-FDG PET/CT is higher in symptomatic compared with asymptomatic patients.
    Skagen K; Johnsrud K; Evensen K; Scott H; Krohg-Sørensen K; Reier-Nilsen F; Revheim ME; Fjeld JG; Skjelland M; Russell D
    Int J Stroke; 2015 Jul; 10(5):730-6. PubMed ID: 25588553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
    Wykrzykowska J; Lehman S; Williams G; Parker JA; Palmer MR; Varkey S; Kolodny G; Laham R
    J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries.
    Silvera SS; Aidi HE; Rudd JH; Mani V; Yang L; Farkouh M; Fuster V; Fayad ZA
    Atherosclerosis; 2009 Nov; 207(1):139-43. PubMed ID: 19467659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.